Ashley Makepeace

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Significant inverse relationship between serum free T4 concentration and body mass index in euthyroid subjects: differences between smokers and nonsmokers

Ashley Makepeace, Alexandra Bremner, Peter O’Leary et al. · Clinical Endocrinology · 2008 · 89 citations

Public Health, Endocrinology, Behavioral Epidemiology +13

Incidence and Predictors of Hospitalization for Bacterial Infection in Community-Based Patients with Type 2 Diabetes: The Fremantle Diabetes Study

Emma Hamilton, Natalie Martin, Ashley Makepeace et al. · PLoS ONE · 2013 · 76 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +17

Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II

Wendy A. Davis, Kirsten E. Peters, Ashley Makepeace et al. · Internal Medicine Journal · 2018 · 65 citations · Full text

Public Health, Health Sciences, Public Health Practice +17